Welcome to our dedicated page for TILRAY BRANDS news (Ticker: TLRY), a resource for investors and traders seeking the latest updates and insights on TILRAY BRANDS stock.
Tilray Brands Inc. (TLRY) maintains a dynamic presence in global cannabis markets through its medical research initiatives and consumer product innovations. This resource provides investors and industry observers with centralized access to verified corporate announcements, regulatory developments, and market analysis.
Users will find updates spanning earnings reports, international expansion efforts, and product portfolio enhancements, including developments in cannabis-infused wellness solutions. The curated selection enables stakeholders to track operational milestones across Tilray's pharmaceutical-grade production facilities and lifestyle brand divisions.
All content undergoes strict verification to ensure alignment with financial disclosure standards and industry regulations. Regular updates reflect Tilray's position as a GMP-certified producer serving medical markets in 20+ countries while expanding recreational offerings in emerging markets.
Bookmark this page for streamlined monitoring of Tilray's strategic initiatives, quality control advancements, and responses to evolving cannabis legislation worldwide.
Tilray Medical (NASDAQ: TLRY) has announced the expansion of its medical cannabis portfolio in Germany with three new EU-GMP certified strains under the Good Supply brand. The new products include Good Supply Cannabisblüten THC 22 IIM, THC 25 MMK, and THC 18 LLD, which will be available in both 15g and 500g sizes.
The rollout will begin in September 2025, with THC 22 IIM launching first, followed by THC 25 MMK on September 19, and THC 18 LLD by early October. These products will be distributed through Tilray's German logistics network and dispensed by prescription through pharmacies, reinforcing the company's position in Europe's largest medical cannabis market.
Tilray Brands (Nasdaq: TLRY) has successfully regained compliance with Nasdaq's minimum bid price requirement. The company's shares maintained a closing bid price of at least $1.00 for 10 consecutive trading days from August 13, 2025 to August 26, 2025, meeting the listing requirement under Rule 5450(a)(1).
CEO Irwin Simon emphasized the company's commitment to growth and innovation, highlighting Tilray's position as a leader in the cannabis, beverage, and wellness industries. With its global platform and international distribution network, Tilray continues to focus on delivering innovative products and experiences to consumers worldwide.
Breckenridge Distillery, owned by Tilray Brands (NASDAQ: TLRY), has launched Mountain Shot, an innovative mushroom-infused whiskey product. This unique beverage combines whiskey with Japanese maitake mushrooms, featuring chocolate and mint flavors.
Available in both whiskey-based (69 proof) and malt-based (30 proof) varieties, Mountain Shot comes in multiple formats: 750ml bottles, 1-liter bottles, and 100ml resealable pouches. The malt-based version will be distributed through convenience stores. The product is currently available in select U.S. markets.
Tilray Brands (Nasdaq: TLRY) has submitted an application for an extension to regain compliance with Nasdaq's minimum share price listing requirements. The company is considering several options, including a potential stockholder-approved Reverse Stock Split to maintain its Nasdaq listing.
CEO Irwin Simon noted that Tilray's stock has seen recent appreciation following President Trump's cannabis rescheduling review, which he believes reflects investor confidence in the company's global platform. The company aims to leverage its position in cannabis, beverage, and wellness industries while giving the market additional time to recognize its business strategy value.
Tilray Medical (NASDAQ:TLRY) has announced a strategic partnership between its subsidiary FL Group and Molteni, a prominent Italian pharmaceutical company specializing in pain therapies. The collaboration aims to expand access to medical cannabis extracts across Italy.
Through this partnership, Molteni will leverage its extensive network of pharmaceutical, scientific, and medical professionals to provide targeted education on medical cannabis therapies. The initiative combines FL Group's regulatory and distribution expertise with Molteni's scientific leadership to enhance patient care and medical cannabis education for pain management.
Tilray Medical maintains a strong presence in the European medical cannabis market, with operations across Germany, Italy, Portugal, Poland, and the United Kingdom.
Tilray Brands (NASDAQ: TLRY) has expanded its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new 10mg format extensions for two of its brands. Fizzy Jane's sparkling seltzers, previously available in 5mg format, now offers 10mg HDD9 drinks in Vanilla, Blood Orange, and Lemon Lime flavors across 10 states. Happy Flower introduces its "Super Bloom" Collection, featuring 10mg versions of Margarita, Strawberry Daiquiri, and Peach Bellini cocktails.
Both brands are launching new variety packs and expanding retail presence. Fizzy Jane's is priced at $15.99 per 5mg 4-pack and $17.99 per 10mg 4-pack, while Happy Flower retails for $17.99 for 5mg 4-packs and $19.99 for 10mg options.
Tilray Brands (NASDAQ: TLRY) has announced the launch of its new Whole Wheat Protein Crackers under The Humble Seed brand, exclusively at select Whole Foods Market stores nationwide. The crackers feature 5g of plant-based protein per serving and are available in three flavors: Sea Salt, Garlic Herb, and Rosemary Sea Salt.
The innovative snack combines a blend of superseeds (hemp, chia, flax, pumpkin, sesame, and sunflower) with whole wheat flour. Each 30g serving contains approximately 21 bite-sized crackers. The products are plant-based, Non-GMO Project Verified, Kosher, and soy-free, targeting the growing market demand for protein-rich snack alternatives.
Tilray Brands (NASDAQ:TLRY) reported its Q4 and fiscal 2025 results, achieving $821.3 million in annual revenue (up 4% YoY) and $224.5 million in Q4 revenue. The company recorded a significant non-cash impairment charge of $1.39 billion in Q4, primarily related to goodwill from the 2021 Aphria-Tilray merger.
Key highlights include 19% growth in beverage revenue to $240.6 million, 71% growth in Q4 international cannabis revenue, and a 700 basis point improvement in global cannabis gross margin. The company maintains a strong balance sheet with $256 million in cash and marketable securities and has reduced total debt by approximately $100 million.
For FY2026, Tilray expects adjusted EBITDA between $62-72 million, representing 13-31% growth compared to FY2025.
Tilray Brands' (NASDAQ: TLRY) Breckenridge Distillery has launched Casa Breck Tequila, marking its strategic entry into the tequila market. The new product line debuts with two varieties: Casa Breck Blanco (SRP: $32.99-$34.99) and Casa Breck Reposado (SRP: $37.99-$39.99).
The tequila is crafted in Jalisco, Mexico, using hand-harvested blue agave and features a unique aging process where the Reposado variant matures in Breckenridge Bourbon Whiskey barrels. The product represents a fusion between Mexican tequila-making traditions and the distillery's Rocky Mountain heritage.
Casa Breck Blanco features notes of cooked agave, vanilla, honey, and lemongrass, while the Reposado offers flavors of cooked agave, vanilla, caramel, oak, and black pepper.
Breckenridge Distillery, owned by Tilray Brands (NASDAQ: TLRY), has launched Mock One, a premium line of non-alcoholic spirit alternatives. The new product line includes alcohol-free versions of whiskey, gin, tequila, and rum, crafted using the distillery's award-winning blending techniques.
The launch leverages Breckenridge's expertise as one of America's most awarded craft distilleries, having received nine Icons of Whisky awards. Mock One is initially available in Colorado retailers and nationwide online, with plans for nationwide retail distribution this fall. Each variant features carefully crafted flavor profiles using natural ingredients to replicate traditional spirits' taste profiles.
FAQ
What is the current stock price of TILRAY BRANDS (TLRY)?
What is the market cap of TILRAY BRANDS (TLRY)?
